Home › Funds › Aristides Capital LLC › ETON
Aristides Capital LLC position in ETON
ETON PHARMACEUTICALS INC · Health Care
Aristides Capital LLC reported holding 86,250 shares of ETON (ETON PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$4.4M, representing 0.77% of its reported portfolio and ranking #35 among its reported holdings. Aristides Capital LLC has disclosed ETON holdings in 10 of the last 10 reported quarters, going back to Q2 2024.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Aristides Capital LLC's ETON position evolved
Aristides Capital LLC first disclosed a stake in ETON in Q2 2024 at 200,000 shares (US$658K). The position peaked in Q2 2026 at 145,410 shares, worth US$5.3M. Across 10 filings, Aristides Capital LLC increased the stake 2 time(s), trimmed it 4 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 86,250 shares valued at US$4.4M — a reduction of -59,160 shares quarter over quarter.. Notable position changes include a 31% trim in Q2 2025 (shares rose 52% over the following quarter), a 41% trim in Q3 2026 (shares rose 24% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2024 | 200.00K | $658.00K | New |
| Q3 2024 | 200.00K | $1.20M | Hold |
| Q4 2024 | 241.59K | $3.22M | Add |
| Q1 2025 | 241.59K | $3.14M | Hold |
| Q2 2025 | 167.59K | $2.39M | Reduce |
| Q3 2025 | 167.59K | $3.64M | Hold |
| Q4 2025 | 161.44K | $2.73M | Reduce |
| Q1 2026 | 186.04K | $4.59M | Add |
| Q2 2026 | 145.41K | $5.26M | Reduce |
| Q3 2026 | 86.25K | $4.44M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ETON and 13F data
ETON (ETON PHARMACEUTICALS INC) is a Health Care company. 69 other funds we track also report a position in ETON — the largest reported positions include EcoR1 Capital, LLC (US$127.2M), Opaleye Management Inc. (US$103.5M), Nantahala Capital Management, LLC (US$45.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ETON
- EcoR1 Capital, LLC 2.47M sh · $127.23M · Q3 2026
- Opaleye Management Inc. 2.86M sh · $103.53M · Q2 2026
- Nantahala Capital Management, LLC 875.51K sh · $45.08M · Q3 2026
- National Philanthropic Trust 492.11K sh · $25.34M · Q3 2026
- Westside Investment Management, Inc. 401.38K sh · $20.67M · Q3 2026
- Pillsbury Lake Capital LLC 288.27K sh · $14.84M · Q3 2026
- Lumbard & Kellner, LLC 173.26K sh · $8.92M · Q3 2026
- Panoramic Capital, LLC 208.19K sh · $7.54M · Q2 2026
- Informed Momentum Co LLC 139.21K sh · $7.17M · Q3 2026
- CANNELL CAPITAL LLC 170.75K sh · $6.18M · Q2 2026
- Prospect Capital Advisors, LLC 157.20K sh · $5.69M · Q2 2026
- PRELUDE CAPITAL MANAGEMENT, LLC 97.58K sh · $5.02M · Q3 2026
More on Aristides Capital LLC
FAQ
How long has Aristides Capital LLC held ETON?
Aristides Capital LLC has disclosed ETON holdings in 10 of the last 10 reported quarters, going back to Q2 2024.
What is Aristides Capital LLC's current position in ETON?
As of Q3 2026, Aristides Capital LLC holds 86.25K shares of ETON (ETON PHARMACEUTICALS INC), valued at $4.44M, representing 0.77% of its reported portfolio and ranking #35.
Has Aristides Capital LLC been buying or selling ETON?
In the latest 13F filing (Q3 2026), Aristides Capital LLC reduced its position in ETON. The position peaked in Q2 2026 at 145.41K shares.
Which other funds hold ETON?
Other major institutional holders of ETON include EcoR1 Capital, LLC, Opaleye Management Inc., Nantahala Capital Management, LLC, among 69 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.